Acromegaloid Facial Appearance SyndromeSymptoms, Doctors, Treatments, Advances & More
Acromegaloid Facial Appearance Syndrome Overview
Learn About Acromegaloid Facial Appearance Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cedars-Sinai Pituitary Center
Shlomo Melmed is an Endocrinologist practicing medicine in Los Angeles, California. Dr. Melmed is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, Pituitary Tumor, and Hormone Replacement Therapy (HRT).
Northwestern Medical Faculty Foundation
Mark Molitch is an Endocrinologist practicing medicine in Chicago, Illinois. Dr. Molitch is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaly, Diabetic Nephropathy, and Hormone Replacement Therapy (HRT).
Stanford University
Laurence Katznelson is an Endocrinologist practicing medicine in Palo Alto, California. Dr. Katznelson is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Acromegaly, Cushing's disease, Pituitary Tumor, Hypopituitarism, and Hormone Replacement Therapy (HRT).
Summary: The primary objective of this study is to evaluate the efficacy of 15-week treatment with ALXN2420 versus placebo for decreasing insulin-like growth factor IGF-1 levels, when administered in combination with somatostatin analog (SSA) therapy to adult participants with acromegaly.
Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...